Repligen (RGEN) earnings

Earnings (net income) · fiscal 2025
$48.89M

Repligen (RGEN) reported net income of $48.89M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$25.51M. Figures as of 18 Nov 2026, 03:58 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$48.89M
Growth, 5 years
−4.0% a year
Growth, 10 years
+18.0% a year
Highest on record
$185.96Mfiscal 2022
Lowest on record
-$25.51Mfiscal 2024
Fiscal years on record
172010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Repligen earnings, in more detail

Over the five fiscal years to 2025 net income shrank at a compound 4.0% a year; over ten years the rate was 18.0% a year. Across the 17 fiscal years on record (2010–2025), the highest was $185.96M in fiscal 2022 and the lowest -$25.51M in fiscal 2024.

History · 17 fiscal years

Earnings (net income) by fiscal year

Repligen earnings, year by year

Repligen (RGEN) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$48.89M—
2024-$25.51M 171.7% down
2023$35.60M 80.9% down
2022$185.96M 45.0% up
2021$128.29M 114.1% up
2020$59.93M 179.9% up
2019$21.41M 28.8% up
2018$16.62M 41.4% down
2017$28.35M 142.7% up
2016$11.68M 25.0% up
2015$9.35M 14.4% up
2014$8.17M 49.2% down
2013$16.09M 13.7% up
2012$14.16M—
2011-$1.61M—
2011-$43.51K—
2010-$4.06M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Repligen and comparable companies
CompanyEarnings (net income)Fiscal year
Kymera Therapeutics KYMR-$311.35M2025
DaVita DVA$746.80M2025
Halozyme Therapeutics HALO$316.89M2025
Universal Health Services UHS$1.49B2025
Repligen RGEN$48.89M2025
Bio-Techne TECH$181.86M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RGEN

Repligen, figure by figure

Repligen (RGEN) overview: price, valuation and scorecardAll health care companies by market value

Repligen earnings: questions and answers

What is Repligen's net income?

Repligen (RGEN) reported net income of $48.89M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$25.51M.

What is the growth rate of Repligen's net income?

Over the five fiscal years to 2025 net income shrank at a compound 4.0% a year; over ten years the rate was 18.0% a year.

What are the highest and lowest net income figures on record for Repligen?

Across the 17 fiscal years on record (2010–2025), the highest was $185.96M in fiscal 2022 and the lowest -$25.51M in fiscal 2024.

How is Repligen's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Repligen (RGEN) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/RGEN/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.